Ratio of observed bleeding events compared to the expected number based on patient risk factors and procedure characteristics.

Percentage of patients undergoing PCI who required a transfusion of red blood cells or whole blood during the hospitalization.

Composite endpoint measuring the occurrence of in-hospital death, need for emergency coronary artery bypass graft (CABG) surgery, stroke, or repeat target vessel revascularization (RTVR) after PCI.

Percentage of PCI cases where fluoroscopy time exceeds 60 minutes.

Mean hospital stay (in days) for patients undergoing PCI without additional cardiac surgical or procedural interventions.

Mean hospital stay (in days) for patients undergoing PCI specifically for ST-elevation myocardial infarction (STEMI).

Percentage of elective PCI patients who are safely discharged on the same day as their procedure.

Mean number of days between completion of PCI and patient discharge.

Percentage of PCI patients who developed new or worsening kidney injury during hospitalization.

Percentage of PCI patients developing AKI, stratified by radial vs. femoral access.

Ratio of observed AKI events to expected AKI events based on patient characteristics and risk models.

Mean volume of contrast agent administered during PCI.

Mean cumulative radiation dose (measured in air kerma, mGy) during PCI.

Percentage of patients who died during the same hospitalization as their PCI procedure.

Mean time from beginning of the procedure to the end, measured in minutes.

Percentage of patients discharged on all guideline-directed medical therapies (e.g., aspirin, P2Y12 inhibitor, statin).

Percentage of patients referred to outpatient cardiac rehabilitation at hospital discharge.

Ratio of observed bleeding events compared to the expected number based on patient risk factors and procedure characteristics.

Percentage of percutaneous coronary interventions (PCI) performed using radial artery access (versus femoral access).